Clinical trial
Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable…
NCT00030082 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00030082 |
|---|---|
| Title | Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer |
| Official title | A Phase I Study of Hepatic Arterial Infusion of Escalating Dose Melphalan With Venous Filtration for Metastatic Unresectable Cancers of the Liver |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Cancer, Metastatic Cancer |
| Intervention type | Drug |
| Interventions | isolated perfusion, melphalan |
| Start date | Jul 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: